In addition, as a direct anti-tumor effect of metformin, AMP-activated protein kinase (AMPK) activation-mediated mTOR inhibition, the suppression of cancer stem cells, and the inhibition of cellular transformation are involved in the mechanisms of tumor suppression by metformin [9,10]. This evidence concerns the gene MTOR and neoplasm.